Titlebook: Current Topics in Complement II; John D. Lambris Book 2008 The Editor(s) (if applicable) and The Author(s), under exclusive license to Spr

显示全部楼层 · 发表于 2025-3-27 00:13:53

Regulation of Tissue Inflammation by Thrombin-Activatable Carboxypeptidase B (or TAFI),.

显示全部楼层 · 发表于 2025-3-27 02:56:26

显示全部楼层 · 发表于 2025-3-27 05:41:59

显示全部楼层 · 发表于 2025-3-27 13:25:05

Complement Factor H: Using Atomic Resolution Structure to Illuminate Disease Mechanisms,.

显示全部楼层 · 发表于 2025-3-27 15:12:11

显示全部楼层 · 发表于 2025-3-27 21:41:02

显示全部楼层 · 发表于 2025-3-27 23:34:22

显示全部楼层 · 发表于 2025-3-28 04:57:33

Human Astrovirus Coat Protein: A Novel C1 Inhibitor,.

显示全部楼层 · 发表于 2025-3-28 06:16:52

Targeting Classical Complement Pathway to Treat Complement Mediated Autoimmune Diseases,

显示全部楼层 · 发表于 2025-3-28 13:49:36

0065-2598 Complement research is now faced with the challenge of trying to integrate isolated biochemical pathways into complex gene and protein regulatory circu978-1-4419-2706-4978-0-387-78952-1Series ISSN 0065-2598 Series E-ISSN 2214-8019

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-4 04:49
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved